三尖瓣成形術(shù)與置換術(shù)治療中重度三尖瓣關(guān)閉不全的效果分析
[Abstract]:Objective to compare the early and intermediate survival rate and complication rate of tricuspid valvuloplasty and tricuspid valve replacement in the treatment of moderate and severe tricuspid insufficiency, and to evaluate the effect of tricuspid valvuloplasty and tricuspid valve replacement in the treatment of moderate and severe tricuspid insufficiency. To provide reference for this kind of operation. Methods from January 2003 to June 2008, patients with tricuspid insufficiency complicated with left heart valve disease or congenital heart disease in our hospital were analyzed retrospectively. Some of the patients had edema of lower extremity and filling of jugular vein. 228 patients underwent tricuspid valve operation after cardiac function improvement, including 127 patients underwent tricuspid valve replacement and 101 patients underwent tricuspid valve replacement. The data of perioperative period were collected and followed up for 65 months to evaluate the efficacy of two surgical methods in the treatment of moderate and severe tricuspid insufficiency with right heart failure. Results the mean age of tricuspid valve replacement group was (57.97 鹵9.24) years old. There were 52 males and 49 females with mean age of (57.87 鹵9.35) years. There were 68 cases of moderate tricuspid regurgitation, 49 cases of severe regurgitation and 41 cases of moderate and severe regurgitation in tricuspid valve replacement group. In tricuspid valve replacement group, there were 22 cases (17.3%) with II grade III, 79 cases (62.2%) with II grade III and 26 cases (20.5%) with grade IV cardiac function. In tricuspid valve replacement group, there were 11 cases (10.9%) with II grade III and 34 cases (33.7%) with cardiac function. The abnormal rate of liver function in tricuspid valvuloplasty group (4.4%) was lower than that in tricuspid valve replacement group (10.9%) (P0. 023). The mean pulmonary arterial systolic pressure (PAP) in tricuspid valve plasty group was (53.48 鹵14.32) mmHg lower than that in tricuspid valve replacement group (57.62 鹵14.65) mmHg (P0. 033). Mean aortic occlusion time in the replacement group, The time of cardiopulmonary bypass (CPB), ventilator assisted time and ICU residence time were significantly higher than those in tricuspid valvuloplasty group (P0.01), the diameter of right atrium and right ventricle in the early postoperative group was significantly higher than that in tricuspid valvuloplasty group (P0.01). There was no significant difference in left ventricular ejection fraction (LVEF) and pulmonary systolic blood pressure (P < 0.05). There were 20 cases of early complications in tricuspid valve plasty group (15.75%) and 27 cases in tricuspid valve replacement group (P < 0.05). The complication rate was 27.27% (P0. 042). The mortality rate (6. 3%) in tricuspid valve plasty group was lower than that in tricuspid valve replacement group (17 cases) (16. 83%) (P0. 011). Long-term follow-up showed that 33 cases (28.7%) of tricuspid regurgitation in tricuspid valvuloplasty group were higher than 7 cases (8.75%) in tricuspid valve replacement group, and 9 cases in tricuspid valve replacement group (n = 18) had cardiac function grade I, grade II and grade III. In the tricuspid valve replacement group, the cardiac function grade I and II grade III were 11 cases and 59 cases respectively, the difference was not statistically significant (P = 0.713 0. 659 0. 279), the survival rate of 3 months, 1 year, 3 years and 5 years in the tricuspid valve replacement group was higher than that in the tricuspid valve replacement group, and the survival rate in the tricuspid valve replacement group was higher than that in the tricuspid valve replacement group. But the difference was not statistically significant (P = 0.231, 0.089, 0.133, 0.078, respectively). Conclusion tricuspid valvuloplasty is superior to tricuspid valve replacement in the treatment of patients with moderate and severe tricuspid insufficiency, and the recurrence rate of middle and severe tricuspid regurgitation after tricuspid valvuloplasty is higher than that of tricuspid valve replacement.
【學位授予單位】:天津醫(yī)科大學
【學位級別】:碩士
【學位授予年份】:2015
【分類號】:R654.2
【共引文獻】
相關(guān)期刊論文 前4條
1 葉斯;葛建軍;樊揚名;;68例心臟瓣膜病繼發(fā)重度肺動脈高壓的外科治療[J];重慶醫(yī)學;2015年27期
2 黃煥雷;魏大闖;盧聰;劉菁;郭惠明;肖學鈞;;左心瓣膜置換術(shù)后孤立性三尖瓣關(guān)閉不全的外科治療及危險因素[J];嶺南心血管病雜志;2013年05期
3 佟明匯;史藝;許建屏;;功能性三尖瓣關(guān)閉不全患者的外科再次手術(shù)治療[J];臨床和實驗醫(yī)學雜志;2015年08期
4 趙金龍;張衛(wèi);石■;葉偉;;心臟術(shù)后繼發(fā)性三尖瓣關(guān)閉不全再次行三尖瓣置換術(shù)的危險因素分析[J];上海交通大學學報(醫(yī)學版);2015年09期
相關(guān)博士學位論文 前2條
1 付紹梓;三尖瓣成形術(shù)中人造瓣環(huán)尺寸的選擇[D];浙江大學;2015年
2 朱鐵源;繼發(fā)性三尖瓣反流的術(shù)中量化干預(yù)指征[D];首都醫(yī)科大學;2015年
相關(guān)碩士學位論文 前6條
1 鄭濤;三尖瓣置換手術(shù)13例診療分析[D];浙江大學;2013年
2 胡鵬;心臟二次手術(shù)20例分析與體會[D];浙江大學;2013年
3 楊紅艷;國產(chǎn)和進口膜式氧合器在心臟瓣膜置換手術(shù)中的應(yīng)用比較[D];吉林大學;2013年
4 劉旭;風濕性二尖瓣病變繼發(fā)中重度三尖瓣返流外科治療近期療效分析[D];蚌埠醫(yī)學院;2014年
5 魏榮偉;Edwards MC3成形環(huán)在治療中重度三尖瓣關(guān)閉不全中的應(yīng)用[D];天津醫(yī)科大學;2014年
6 郭漢原;應(yīng)用機械瓣或生物瓣三尖瓣置換的圍術(shù)期及中遠期療效比較[D];福建醫(yī)科大學;2014年
,本文編號:2222286
本文鏈接:http://sikaile.net/yixuelunwen/waikelunwen/2222286.html